AdjuTec Pharma's
AdjuTec Pharma’s CEO: “We must restore antibiotics”
A new report from the CDC shows a 460 percent increase in infections with NDM-producing superbugs in the United States since...
Bioteknik
AdjuTec Pharma leads €2.2M Eurostars project to combat deadly lung infections
AdjuTec Pharma has signed a €2.2 million Eurostars...
Intervju
AdjuTec Pharma wants to give new power to antibiotics
Antimicrobial resistance poses a growing threat to the...
Intervju
AdjuTec Pharma's APC148 shines at ESCMID congress
At the recent ESCMID congress, organized by the...
AdjuTec Pharma joins forces to fight antibiotic resistance
AdjuTec Pharma has launched a research collaboration with...
AdjuTec Pharma's CEO: “Our goal is to set a new standard in antibiotic treatment”
Late last year, AdjuTec Pharma launched a phase...
Intervju
AdjuTec Pharma enters phase I with novel AMR treatment
AdjuTec Pharma has launched a phase I clinical...
Intervju
New proposal potential game changer for Adjutec Pharma
A group of experts from the DRIVE-AB project...
AdjuTec takes on global antimicrobial resistance
AdjuTec Pharma is determined in its mission to...
See the presentations from the BioStock Investor Meeting!
Last Wednesday, the autumn BioStock Investor Meeting took place...
BioStock Life Science Spring Summit 2023 is about to begin
Today, May 30th at 10 am, BioStock begins...
Video
BioStock Life Science Fall Summit - see all features!
For the fifth year, we invited BioStock...